rollins inc. - ROL
ROL
Close Chg Chg %
51.70 -0.07 -0.13%
Closed Market
51.63
-0.07 (0.13%)
Volume: 3.13M
Last Updated:
Mar 21, 2025, 3:59 PM EDT
Company Overview: rollins inc. - ROL
ROL Key Data
| Open $51.64 | Day Range 51.18 - 51.81 |
| 52 Week Range 41.73 - 53.72 | Market Cap $25.07B |
| Shares Outstanding 485.08M | Public Float 290.51M |
| Beta 0.78 | Rev. Per Employee N/A |
| P/E Ratio 54.03 | EPS $0.96 |
| Yield 121.08% | Dividend $0.17 |
| EX-DIVIDEND DATE Feb 25, 2025 | SHORT INTEREST N/A |
| AVERAGE VOLUME 1.80M |
ROL Performance
| 1 Week | 0.54% | ||
| 1 Month | 0.76% | ||
| 3 Months | 10.14% | ||
| 1 Year | 11.04% | ||
| 5 Years | 121.49% |
ROL Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
14
Full Ratings ➔
About rollins inc. - ROL
Rollins, Inc. is an international services company, which engages in the provision of pest and termite control services. Its service offerings include Residential, Commercial, and Termite. The company was founded by John W. Rollins Jr. and O. Wayne Rollins Sr. in 1948 and is headquartered in Atlanta, GA.
ROL At a Glance
Rollins, Inc.
2170 Piedmont Road NE
Atlanta, Georgia 30324-4135
| Phone | 1-404-888-2000 | Revenue | 3.39B | |
| Industry | Other Consumer Services | Net Income | 466.38M | |
| Sector | Consumer Services | 2024 Sales Growth | 10.264% | |
| Fiscal Year-end | 12 / 2025 | Employees | 20,265 | |
| View SEC Filings |
ROL Valuation
| P/E Current | 53.925 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 48.131 |
| Price to Sales Ratio | 6.624 |
| Price to Book Ratio | 16.873 |
| Price to Cash Flow Ratio | 36.941 |
| Enterprise Value to EBITDA | 29.992 |
| Enterprise Value to Sales | 6.837 |
| Total Debt to Enterprise Value | 0.035 |
ROL Efficiency
| Revenue/Employee | 167,219.738 |
| Income Per Employee | 23,014.014 |
| Receivables Turnover | 14.336 |
| Total Asset Turnover | 1.252 |
ROL Liquidity
| Current Ratio | 0.656 |
| Quick Ratio | 0.595 |
| Cash Ratio | 0.14 |
ROL Profitability
| Gross Margin | 49.349 |
| Operating Margin | 19.455 |
| Pretax Margin | 18.598 |
| Net Margin | 13.763 |
| Return on Assets | 17.225 |
| Return on Equity | 37.518 |
| Return on Total Capital | 21.762 |
| Return on Invested Capital | 23.908 |
ROL Capital Structure
| Total Debt to Total Equity | 61.065 |
| Total Debt to Total Capital | 37.913 |
| Total Debt to Total Assets | 28.816 |
| Long-Term Debt to Equity | 51.947 |
| Long-Term Debt to Total Capital | 32.252 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Rollins Inc. - ROL
Collapse All in section
| All values USD millions. | 2021 | 2022 | 2023 | 2024 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 2.42B | 2.70B | 3.07B | 3.39B | |
Sales Growth
| +12.17% | +11.20% | +14.00% | +10.26% | |
Cost of Goods Sold (COGS) incl D&A
| 1.26B | 1.40B | 1.57B | 1.72B | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 94.20M | 91.33M | 99.75M | 113.22M | |
Depreciation
| 40.59M | 35.65M | 33.30M | 34.10M | |
Amortization of Intangibles
| 53.61M | 55.68M | 66.45M | 79.12M | |
COGS Growth
| +10.55% | +11.37% | +12.14% | +9.35% | |
Gross Income
| 1.17B | 1.30B | 1.50B | 1.67B | |
Gross Income Growth
| +13.98% | +11.02% | +16.01% | +11.22% | |
Gross Profit Margin
| +48.16% | +48.08% | +48.93% | +49.35% |
| 2021 | 2022 | 2023 | 2024 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| 727.49M | 802.71M | 912.13M | 1.01B | |
Research & Development
| - | - | - | - | - |
Other SG&A
| 727.49M | 802.71M | 912.13M | 1.01B | |
SGA Growth
| +10.86% | +10.34% | +13.63% | +11.06% | |
Other Operating Expense
| - | - | - | - | - |
Unusual Expense
| - | - | 8.30M | 2.05M | - |
EBIT after Unusual Expense
| 439.99M | 493.39M | 583.23M | 657.22M | |
Non Operating Income/Expense
| 35.28M | 8.17M | 22.09M | 683.00K | |
Non-Operating Interest Income
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Interest Expense
| 430.00K | 2.64M | 19.05M | 27.68M | |
Interest Expense Growth
| -90.19% | +513.49% | +622.33% | +45.25% | |
Gross Interest Expense
| 430.00K | 2.64M | 19.05M | 27.68M | |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| 474.84M | 498.92M | 586.26M | 630.23M | |
Pretax Income Growth
| +33.86% | +5.07% | +17.51% | +7.50% | |
Pretax Margin
| +19.59% | +18.51% | +19.08% | +18.60% | |
Income Tax
| 124.15M | 130.32M | 151.30M | 163.85M | |
Income Tax - Current - Domestic
| 112.02M | 119.58M | 146.16M | 162.57M | |
Income Tax - Current - Foreign
| 10.48M | 9.14M | 12.78M | 11.61M | |
Income Tax - Deferred - Domestic
| 1.76M | 1.68M | (5.27M) | (9.18M) | |
Income Tax - Deferred - Foreign
| (109.00K) | (83.00K) | (2.37M) | (1.15M) | |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| 350.69M | 368.60M | 434.96M | 466.38M | |
Minority Interest Expense
| - | - | - | - | - |
Net Income
| 350.69M | 368.60M | 434.96M | 466.38M | |
Net Income Growth
| +34.45% | +5.11% | +18.00% | +7.22% | |
Net Margin Growth
| +14.47% | +13.67% | +14.15% | +13.76% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| 350.69M | 368.60M | 434.96M | 466.38M | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| 350.69M | 368.60M | 434.96M | 466.38M | |
EPS (Basic)
| 0.7127 | 0.7487 | 0.8878 | 0.9631 | |
EPS (Basic) Growth
| +34.32% | +5.05% | +18.58% | +8.48% | |
Basic Shares Outstanding
| 492.05M | 492.30M | 489.95M | 484.25M | |
EPS (Diluted)
| 0.7127 | 0.7486 | 0.8874 | 0.963 | |
EPS (Diluted) Growth
| +34.32% | +5.04% | +18.54% | +8.52% | |
Diluted Shares Outstanding
| 492.05M | 492.41M | 490.13M | 484.30M | |
EBITDA
| 534.19M | 584.71M | 691.27M | 772.49M | |
EBITDA Growth
| +17.04% | +9.46% | +18.22% | +11.75% | |
EBITDA Margin
| +22.03% | +21.69% | +22.49% | +22.80% |
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 52.50 | |
| Number of Ratings | 14 | Current Quarters Estimate | 0.222 | |
| FY Report Date | 03 / 2025 | Current Year's Estimate | 1.102 | |
| Last Quarter’s Earnings | 0.22 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 0.96 | Next Fiscal Year Estimate | 1.234 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 8 | 8 | 9 | 9 |
| Mean Estimate | 0.22 | 0.30 | 1.10 | 1.23 |
| High Estimates | 0.23 | 0.31 | 1.14 | 1.30 |
| Low Estimate | 0.21 | 0.30 | 0.99 | 1.13 |
| Coefficient of Variance | 2.87 | 1.18 | 4.25 | 4.09 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 5 | 5 | 5 |
| OVERWEIGHT | 0 | 0 | 0 |
| HOLD | 8 | 8 | 6 |
| UNDERWEIGHT | 1 | 1 | 2 |
| SELL | 0 | 0 | 0 |
| MEAN | Overweight | Overweight | Overweight |
SEC Filings for Rollins Inc. - ROL
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Rollins Inc. - ROL
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Mar 11, 2025 | Thomas D. Tesh Chief Admin. Officer | 41,173 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $51.78 per share | 2,131,937.94 |
| Mar 6, 2025 | Traci Hornfeck PRINCIPAL ACCOUNTING OFFICER | 9,602 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $53.1 per share | 509,866.20 |
| Feb 21, 2025 | Elizabeth Brannen Chandler CLO, GC, CORPORATE SECRETARY | 77,480 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $50.01 per share | 3,874,774.80 |
| Feb 21, 2025 | Gary W. Rollins EXECUTIVE CHAIRMAN EMERITUS; Director | 5,219,064 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $50.01 per share | 261,005,390.64 |
| Feb 21, 2025 | John F. Wilson EXECUTIVE CHAIRMAN; Director | 660,507 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $50.01 per share | 33,031,955.07 |
| Feb 21, 2025 | Kenneth D. Krause EXEC. VP AND CFO | 79,639 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $50.01 per share | 3,982,746.39 |
| Feb 21, 2025 | Jerry E. Gahlhoff PRESIDENT & CEO; Director | 274,049 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $50.01 per share | 13,705,190.49 |
| Aug 27, 2024 | John F. Wilson VICE CHAIRMAN; Director | 684,716 | Bona fide gift | 0.00 |
| May 1, 2024 | Gregory B. Morrison Director | 5,937 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 1, 2024 | P. Russell Hardin Director | 10,155 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 1, 2024 | Louise Scott Sams Director | 5,937 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 1, 2024 | Donald P. Carson Director | 5,937 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 1, 2024 | Patrick J. Gunning Director | 5,937 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 1, 2024 | Dale E. Jones Director | 2,228 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 1, 2024 | Pamela R. Rollins Director | 492,277 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 1, 2024 | Susan R. Bell Director | 6,087 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Rollins Inc. in the News
Pest control company Orkin declares Chicago 'rattiest' city again. How do other cities stack up?
The Windy City remained the most rodent-infested American city for yet another year, according to Orkin. The pest control company dubbed it as such on Monday.